Brecht Vanneste, Managing Director, MSD
Drugmaker MSD has announced the appointment of Brecht Vanneste as Managing Director of MSD (India), from March 1, 2026.
He will replace Rehan A Khan, who was appointed in 2020 as head of MSD, also referred to as Merck & Co Inc in the United States and Canada.
Industry veteran
Brecht is a biopharmaceutical industry veteran who has been at MSD for more than 27 years, and has held several international leadership roles, the company said.
“Prior to this, he was the Oncology Business Unit Leader of MSD in China where he provided strategic leadership for the introduction of new products and indications across the private market and through financial patient programs,” the note added.
Brecht has also been Managing Director, MSD (Belgium & Luxembourg) where he strengthened MSD’s oncology presence and capabilities, the note said.
His career has spanned sales, marketing, and access – leading both market and regional teams, including as the External Affairs Lead at MSD in Belgium, Franchise Director for Alzheimer’s Disease across Europe and Canada, and Regional Marketing Lead for the Cardiovascular portfolio based in Switzerland, the company said.
Published on February 26, 2026